ALTERITY THERAPEUTICS LIMITED - AMERICAN DEPOSITAR
4.5100
04-February-25 16:45:00
15 minutes delayed
Stocks
-0.4800
-9.62%
Today's range
4.5100 - 5.1000
ISIN
N/A
Source
NASDAQ
-
30 Jan 2025 07:35:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q2 FY25 Quarterly Cash Flow Report
24 Jan 2025 07:35:00 By Nasdaq GlobeNewswire
-
09 Jan 2025 07:25:00 By Nasdaq GlobeNewswire
-
04 Dec 2024 07:35:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
19 Nov 2024 07:25:00 By Nasdaq GlobeNewswire
-
12 Nov 2024 07:35:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
06 Nov 2024 07:35:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
31 Oct 2024 07:35:00 By Nasdaq GlobeNewswire
-
14 Oct 2024 07:35:00 By Nasdaq GlobeNewswire
-
11 Oct 2024 07:35:00 By Nasdaq GlobeNewswire
-
02 Oct 2024 07:35:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
30 Sep 2024 07:35:00 By Nasdaq GlobeNewswire
-
23 Sep 2024 07:35:00 By Nasdaq GlobeNewswire
-
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
31 Jul 2024 07:35:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present at MST Financial Webinar
24 Jul 2024 07:35:00 By Nasdaq GlobeNewswire
-
17 Jul 2024 07:35:00 By Nasdaq GlobeNewswire
-
17 Jul 2024 07:25:00 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
12 Jun 2024 19:22:16 By Nasdaq GlobeNewswire
-
Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study
29 May 2024 19:21:24 By Nasdaq GlobeNewswire
-
08 May 2024 07:25:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >